MAPT and Parkinson disease: NBP and its racemic (L-NBP/DL-NBP) showed protective effects in Parkinson’s disease cell models through reducing cytotoxicity, preserving the dendritic processes surrounding cells, decreasing apoptotic cells, and inhibiting tau protein hyperphosphorylation.